Equimedical

Equimedical is a private medical device company focused on absorbable haemostatic products used in surgery. The company appears to have been founded in 2006 and has marketed products including Equicel, Equitamp, and Equispon for control of bleeding during surgical procedures. Publicly available sources describe the business as developing, manufacturing, packaging, and commercializing haemostatic devices and related surgical products, with distribution activity across multiple international markets. Equimedical is not a drug-development biotech company; it is better characterized as a commercial-stage healthcare manufacturer in the surgical hemostats segment. The company has had regulatory visibility through FDA establishment listings and external safety notices tied to counterfeit products referencing older Equimedical entities or sites.